After adjustment of age, sex, smoking status and BMI, five polymorphisms (KCTD10 rs1477117, KCTD10 rs11066782, KCTD10 rs11613718, KCTD10 rs11615336 and MMAB rs12817689) showed significant associations with dyslipidemia risk in the codominant model (minor homozygote vs. major homozygote) and MMAB rs11067233 was significantly associated with dyslipidemia risk in the additive model. This evidence concerns the gene MMAB and metabolic syndrome.